A detailed history of Granite Investment Partners, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Granite Investment Partners, LLC holds 118,001 shares of LGND stock, worth $13.4 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
118,001
Holding current value
$13.4 Million
% of portfolio
0.52%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$82.7 - $110.11 $9.76 Million - $13 Million
118,001 New
118,001 $11.8 Million
Q1 2021

May 13, 2021

SELL
$99.52 - $215.83 $3.67 Million - $7.97 Million
-36,914 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$80.55 - $106.05 $4.85 Million - $6.39 Million
-60,248 Reduced 62.01%
36,914 $3.67 Million
Q3 2020

Nov 06, 2020

SELL
$89.56 - $126.72 $9.25 Million - $13.1 Million
-103,244 Reduced 51.52%
97,162 $9.26 Million
Q2 2020

Aug 03, 2020

BUY
$68.28 - $123.65 $11.3 Million - $20.4 Million
165,169 Added 468.74%
200,406 $22.4 Million
Q1 2020

May 14, 2020

BUY
$63.37 - $107.88 $723,368 - $1.23 Million
11,415 Added 47.92%
35,237 $2.56 Million
Q4 2019

Feb 10, 2020

BUY
$96.94 - $113.59 $859,760 - $1.01 Million
8,869 Added 59.31%
23,822 $2.48 Million
Q3 2019

Nov 12, 2019

SELL
$86.25 - $120.16 $8,625 - $12,016
-100 Reduced 0.66%
14,953 $1.49 Million
Q2 2019

Aug 07, 2019

SELL
$107.38 - $129.34 $4.65 Million - $5.6 Million
-43,317 Reduced 74.21%
15,053 $1.72 Million
Q1 2019

May 13, 2019

BUY
$105.93 - $142.47 $5.67 Million - $7.63 Million
53,539 Added 1108.24%
58,370 $7.34 Million
Q4 2018

Feb 13, 2019

BUY
$128.36 - $272.13 $620,107 - $1.31 Million
4,831 New
4,831 $656,000
Q2 2018

Aug 06, 2018

SELL
$150.77 - $207.98 $12.5 Million - $17.2 Million
-82,632 Closed
0 $0
Q1 2018

May 04, 2018

SELL
$138.63 - $182.62 $272,546 - $359,030
-1,966 Reduced 2.32%
82,632 $13.6 Million
Q4 2017

Feb 01, 2018

SELL
$128.36 - $147.04 $4.21 Million - $4.82 Million
-32,798 Reduced 27.94%
84,598 $11.6 Million
Q3 2017

Nov 08, 2017

BUY
$120.91 - $137.94 $14.2 Million - $16.2 Million
117,396
117,396 $16 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.92B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.